Achillion Pharmaceuticals Inc Announces Proposed Public Offering Of Common Stock

Wednesday, 20 Feb 2013 04:07pm EST 

Achillion Pharmaceuticals Inc announced that it has commenced an underwritten public offering of $125 million of its common stock. In connection with this offering, Achillion plans to grant the underwriters a 30-day option to purchase additional shares of its common stock. Citigroup and Leerink Swann LLC are acting as joint book-running managers for the offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. 

Company Quote

-0.335 -2.30%
19 Dec 2014